The Senate Parliamentarian reversed course on a small provision in the One Big Beautiful Bill Act that could boost cures for rare diseases.

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

On June 18, 2025, the U.S. Food and Drug Administration (“FDA”) announced an immediate review of new clinical trials that ...

Unicycive, which was seeking approval of oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease on dialysis, said the FDA issued a so-called complete response letter ...

The stunning new details offer a rare look at how technology can be exploited in the high-stakes battle between US law ...

Ultragenyx Pharmaceutical received breakthrough therapy designation from the U.S. Food and Drug Administration for its drug GTX-102, which is designed to treat people with Angelman syndrome. Angelman ...

“She is currently being held under a secured bond of $3 million in the Rowan County Detention Center.” The school’s website reports Owen is an English teacher for grades 6 through 8. McClatchy News ...

Ecuador ‘s most wanted fugitive, a gang leader and drug-lord known as Fito, was captured after hiding out in a bunker underneath a house.

Earn Continuing Education credits and learn about the complex interplay between alcohol use disorder (AUD) and common ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Two parallel goals for Canalevia-CA1 (crofelemer delayed-release tablets): To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...